DirexGroup

DirexGroup is a medical technology company focused on shockwave-based therapeutic and lithotripsy systems rather than drug development. The company markets the Morenova family of low-intensity shockwave therapy platforms across men's health, women's health, vascular, musculoskeletal, kidney disease, alopecia, wound-healing, and aesthetic applications, and also offers extracorporeal shockwave lithotripsy systems for kidney stone treatment. DirexGroup describes itself as having more than 40 years of experience dating back to early lithotripter development in the 1980s and highlights linear, focused, and large-area shockwave technologies. Recent company materials indicate active commercial expansion through collaborations with medical centers in the UAE and China and ongoing clinical work in areas such as chronic prostatitis/chronic pelvic pain syndrome. For a biotech analyst, this is best characterized as a commercial medtech platform company centered on shockwave therapy devices with broad urology and adjacent specialty applications.